Satellos Bioscience Analyst Price Targets

Wall Street analyst price targets and consensus rating for Satellos Bioscience (MSLE).

Price Target Range — 4 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$21Upside to Avg. PT+226.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 8, 2026	Craig-Hallum	Adam Vogel	Initiate	Buy	$24
Aug 17, 2026	HC Wainwright & Co.	Arthur He	Maintained	Buy	$18
Jul 9, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$11→$18
May 18, 2026	HC Wainwright & Co.	Arthur He	Maintained	Buy	$11
Apr 28, 2026	Guggenheim	Debjit Chattopadhyay	Initiate	Buy	$23
Apr 6, 2026	Leerink Partners	Joseph Schwartz	Initiate	Outperform	$20
Mar 30, 2026	HC Wainwright & Co.	Arthur He	PT Raise	Buy	$1→$11
Mar 11, 2026	Cantor Fitzgerald	Yanni Souroutzidis	Initiate	Overweight	—

Analyst Ratings News

PRO
Craig-Hallum Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $24

Craig-Hallum analyst Adam Vogel initiates coverage on Satellos Bioscience (NASDAQ:MSLE) with a Buy rating and announces Price Target of $24.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $18 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Satellos Bioscience (NASDAQ:MSLE) with a Buy and maintains $18 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $18

HC Wainwright & Co. analyst Arthur He maintains Satellos Bioscience (NASDAQ:MSLE) with a Buy and raises the price target from $11 to $18.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $11 Price Target

HC Wainwright & Co. analyst Arthur He reiterates Satellos Bioscience (NASDAQ:MSLE) with a Buy and maintains $11 price target.

Benzinga Newsdesk

PRO
Guggenheim Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $23

Guggenheim analyst Debjit Chattopadhyay initiates coverage on Satellos Bioscience (NASDAQ:MSLE) with a Buy rating and announces Price Target of $23.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $11

HC Wainwright & Co. analyst Arthur He maintains Satellos Bioscience (NASDAQ:MSLE) with a Buy and raises the price target from $1.2 to $11.

Benzinga Newsdesk

Satellos Bioscience Inc

Satellos Bioscience Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Craig-Hallum Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $24

PRO
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $18 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $18

PRO
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $11 Price Target

PRO
Guggenheim Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $23

PRO
HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $11

People Also Watch

People Also Watch

Satellos Bioscience Inc

Satellos Bioscience Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCraig-Hallum Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $24

PROHC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $18 Price Target

PROHC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $18

PROHC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $11 Price Target

PROGuggenheim Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $23

PROHC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $11

People Also Watch

People Also Watch

PRO
Craig-Hallum Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $24

PRO
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $18 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $18

PRO
HC Wainwright & Co. Reiterates Buy on Satellos Bioscience, Maintains $11 Price Target

PRO
Guggenheim Initiates Coverage On Satellos Bioscience with Buy Rating, Announces Price Target of $23

PRO
HC Wainwright & Co. Maintains Buy on Satellos Bioscience, Raises Price Target to $11